• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鼻窦鳞状细胞癌和鼻内翻性乳头状瘤中调节性T细胞的频率、抑制能力、募集及诱导机制

Frequency, suppressive capacity, recruitment and induction mechanisms of regulatory T cells in sinonasal squamous cell carcinoma and nasal inverted papilloma.

作者信息

Lou Hongfei, Fang Jugao, Li Pingdong, Zhou Weiguo, Wang Yang, Fan Erzhong, Li Ying, Wang Hong, Liu Zhongyan, Xiao Lei, Wang Chengshuo, Zhang Luo

机构信息

Department of Otolaryngology Head and Neck Surgery, Beijing TongRen Hospital, Capital Medical University, Beijing, PR China; Beijing Key Laboratory of nasal diseases, Beijing Institute of Otolaryngology, Beijing, PR China.

Department of Otolaryngology Head and Neck Surgery, Beijing TongRen Hospital, Capital Medical University, Beijing, PR China.

出版信息

PLoS One. 2015 May 28;10(5):e0126463. doi: 10.1371/journal.pone.0126463. eCollection 2015.

DOI:10.1371/journal.pone.0126463
PMID:26020249
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4447263/
Abstract

BACKGROUND

Sinonasal squamous cell carcinoma (SSCC) and nasal inverted papilloma (NIP) represent the predominant type of malignant and benign tumors in sinonasal tract, respectively. CD4+ CD25+ Foxp3+ natural regulatory T (Treg) cells might play critical role(s) in the suppression of anti-tumor immune response and thus shed light on tumor progression from benign to malignant.

OBJECTIVE

This study aimed to evaluate the frequency and suppressive capacity of Treg cells in SSCC compared to NIP and further to explore the underlying mechanisms.

PATIENTS AND METHODS

Frequencies of Treg, Th1 and Th2 cells were evaluated by flow cytometry in tissue homogenate and peripheral blood from 31 SSCC patients, 32 NIP patients and 35 normal controls. Treg cells were tested for regulatory function by co-culture with effector T cells. CCR4 and its ligands, CCL22 and CCL17, were analyzed by flow cytometry and Luminex, respectively. The chemoattractant properties of CCR4/CCL22 and CCR4/CCL17 for Treg cells were assessed using the Boyden chamber technique, to elucidate the potential mechanisms of Treg recruitment in tumor microenvironment. Treg cells induction via TGF-β was assessed with transwells after local CD4+ Foxp3+ T cells were assessed by immunohistochemistry and TGF-β concentration was measured by Luminex.

RESULTS

Tumor-infiltrating Treg cells increased significantly from normal to NIP to SSCC (P ≤ 0.001 for normal vs. NIP and P = 0.004 for NIP vs. SSCC). Significantly elevated frequency and enhanced suppression capacity of circulating Treg cells in SSCC were detected compared to NIP and healthy controls, concomitant with Th1 decrease and Th2 increase. Apparently increased CCL22 attracted CCR4-expressing Treg cells to tumor microenvironment in SSCC, compared to NIP. SSCC produced significantly more TGF-β than NIP and thus possessed greater potential for Treg cell induction.

CONCLUSION

Frequency and suppressive capacity of Treg cells enhanced with progression of malignancy from NIP to SSCC. Circulating Treg cells were recruited to tumor tissue via CCR4/CCL22 signalling, whereas tumor-synthesised TGF-β contributed to induction of peripheral Treg cells.

摘要

背景

鼻窦鳞状细胞癌(SSCC)和鼻内翻性乳头状瘤(NIP)分别是鼻窦最主要的恶性和良性肿瘤类型。CD4+CD25+Foxp3+自然调节性T(Treg)细胞可能在抑制抗肿瘤免疫反应中发挥关键作用,从而揭示肿瘤从良性发展为恶性的机制。

目的

本研究旨在评估与鼻内翻性乳头状瘤相比,鼻窦鳞状细胞癌中Treg细胞的频率和抑制能力,并进一步探索其潜在机制。

患者与方法

采用流式细胞术评估31例鼻窦鳞状细胞癌患者、32例鼻内翻性乳头状瘤患者和35例正常对照者的组织匀浆和外周血中Treg、Th1和Th2细胞的频率。通过与效应T细胞共培养检测Treg细胞的调节功能。分别采用流式细胞术和Luminex技术分析CCR4及其配体CCL22和CCL17。采用Boyden小室技术评估CCR4/CCL22和CCR4/CCL17对Treg细胞的趋化特性,以阐明肿瘤微环境中Treg细胞募集的潜在机制。在通过免疫组织化学评估局部CD4+Foxp3+T细胞并采用Luminex技术测量TGF-β浓度后,使用transwell评估TGF-β诱导Treg细胞的情况。

结果

从正常组织到鼻内翻性乳头状瘤再到鼻窦鳞状细胞癌,肿瘤浸润性Treg细胞显著增加(正常与鼻内翻性乳头状瘤相比,P≤0.001;鼻内翻性乳头状瘤与鼻窦鳞状细胞癌相比,P=0.004)。与鼻内翻性乳头状瘤和健康对照相比,鼻窦鳞状细胞癌中循环Treg细胞的频率显著升高且抑制能力增强,同时伴有Th1细胞减少和Th2细胞增加。与鼻内翻性乳头状瘤相比,鼻窦鳞状细胞癌中明显增加的CCL22将表达CCR4的Treg细胞吸引至肿瘤微环境。鼻窦鳞状细胞癌产生的TGF-β明显多于鼻内翻性乳头状瘤,因此具有更强的诱导Treg细胞的潜力。

结论

从鼻内翻性乳头状瘤到鼻窦鳞状细胞癌,随着恶性程度的进展,Treg细胞的频率和抑制能力增强。循环Treg细胞通过CCR4/CCL22信号被募集至肿瘤组织,而肿瘤合成的TGF-β有助于外周Treg细胞的诱导。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e26/4447263/fc7c471d57e3/pone.0126463.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e26/4447263/7a8d39e77fd5/pone.0126463.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e26/4447263/440d8d370085/pone.0126463.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e26/4447263/a38529bbf18e/pone.0126463.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e26/4447263/89c38abc9333/pone.0126463.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e26/4447263/acccd7da37bc/pone.0126463.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e26/4447263/fc7c471d57e3/pone.0126463.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e26/4447263/7a8d39e77fd5/pone.0126463.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e26/4447263/440d8d370085/pone.0126463.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e26/4447263/a38529bbf18e/pone.0126463.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e26/4447263/89c38abc9333/pone.0126463.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e26/4447263/acccd7da37bc/pone.0126463.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e26/4447263/fc7c471d57e3/pone.0126463.g006.jpg

相似文献

1
Frequency, suppressive capacity, recruitment and induction mechanisms of regulatory T cells in sinonasal squamous cell carcinoma and nasal inverted papilloma.鼻窦鳞状细胞癌和鼻内翻性乳头状瘤中调节性T细胞的频率、抑制能力、募集及诱导机制
PLoS One. 2015 May 28;10(5):e0126463. doi: 10.1371/journal.pone.0126463. eCollection 2015.
2
Increased frequencies of CD4+ CD25+ FOXP3+ regulatory T cells in human nasal inverted papilloma.人类鼻腔内翻性乳头状瘤中 CD4+ CD25+ FOXP3+ 调节性 T 细胞的频率增加。
Head Neck. 2011 Jul;33(7):1005-12. doi: 10.1002/hed.21581. Epub 2010 Dec 6.
3
CCL17 and CCL22 chemokines within tumor microenvironment are related to infiltration of regulatory T cells in esophageal squamous cell carcinoma.肿瘤微环境中的趋化因子 CCL17 和 CCL22 与食管鳞状细胞癌中调节性 T 细胞的浸润有关。
Dis Esophagus. 2010 Jul;23(5):422-9. doi: 10.1111/j.1442-2050.2009.01029.x. Epub 2009 Dec 11.
4
CCL17 and CCL22 chemokines within tumor microenvironment are related to accumulation of Foxp3+ regulatory T cells in gastric cancer.肿瘤微环境中的CCL17和CCL22趋化因子与胃癌中Foxp3 +调节性T细胞的积聚有关。
Int J Cancer. 2008 May 15;122(10):2286-93. doi: 10.1002/ijc.23392.
5
Immune suppression in premalignant respiratory papillomas: enriched functional CD4+Foxp3+ regulatory T cells and PD-1/PD-L1/L2 expression.在癌前呼吸性乳头状瘤中免疫抑制:富含功能性 CD4+Foxp3+调节性 T 细胞和 PD-1/PD-L1/L2 表达。
Clin Cancer Res. 2012 Apr 1;18(7):1925-35. doi: 10.1158/1078-0432.CCR-11-2941. Epub 2012 Feb 9.
6
A unique subset of CD4+CD25highFoxp3+ T cells secreting interleukin-10 and transforming growth factor-beta1 mediates suppression in the tumor microenvironment.分泌白细胞介素-10和转化生长因子-β1的CD4+CD25高表达Foxp3+ T细胞的一个独特亚群介导肿瘤微环境中的抑制作用。
Clin Cancer Res. 2007 Aug 1;13(15 Pt 1):4345-54. doi: 10.1158/1078-0432.CCR-07-0472.
7
Synergistic effect of regulatory T cells and proinflammatory cytokines in angiogenesis in the endometriotic milieu.调节性T细胞与促炎细胞因子在子宫内膜异位症环境中血管生成中的协同作用。
Hum Reprod. 2017 Jun 1;32(6):1304-1317. doi: 10.1093/humrep/dex067.
8
Altered frequency and migration capacity of CD4+CD25+ regulatory T cells in systemic lupus erythematosus.系统性红斑狼疮中CD4+CD25+调节性T细胞的频率和迁移能力改变
Rheumatology (Oxford). 2008 Jun;47(6):789-94. doi: 10.1093/rheumatology/ken108. Epub 2008 Apr 3.
9
Association between the low levels of vitamin D and Treg function in systemic lupus erythematosus patients.系统性红斑狼疮患者维生素D水平低下与调节性T细胞功能之间的关联。
Acta Med Indones. 2013 Jan;45(1):26-31.
10
Lower numbers of FoxP3 and CCR4 co-expressing cells in an elevated subpopulation of CD4+CD25high regulatory T cells from Wegener's granulomatosis.韦格纳肉芽肿患者 CD4+CD25high 调节性 T 细胞中高表达亚群 FoxP3 和 CCR4 共表达细胞数量减少。
Clin Exp Rheumatol. 2010 Jan-Feb;28(1 Suppl 57):72-80.

引用本文的文献

1
Biomarkers for Immunotherapy in Poorly Differentiated Sinonasal Tumors.低分化鼻窦肿瘤免疫治疗的生物标志物
Biomedicines. 2022 Sep 6;10(9):2205. doi: 10.3390/biomedicines10092205.
2
Role and Function of Regulatory T Cell in Chronic Rhinosinusitis with Nasal Polyposis.调节性T细胞在伴鼻息肉的慢性鼻-鼻窦炎中的作用及功能
J Immunol Res. 2022 Mar 26;2022:1144563. doi: 10.1155/2022/1144563. eCollection 2022.
3
Endotypes of chronic rhinosinusitis: Relationships to disease phenotypes, pathogenesis, clinical findings, and treatment approaches.

本文引用的文献

1
CD45RA-Foxp3high but not CD45RA+Foxp3low suppressive T regulatory cells increased in the peripheral circulation of patients with head and neck squamous cell carcinoma and correlated with tumor progression.CD45RA-Foxp3高表达而非CD45RA+Foxp3低表达的抑制性调节性T细胞在头颈部鳞状细胞癌患者的外周循环中增加,并与肿瘤进展相关。
J Exp Clin Cancer Res. 2014 Apr 25;33(1):35. doi: 10.1186/1756-9966-33-35.
2
Increased frequency and suppressive activity of CD127(low/-) regulatory T cells in the peripheral circulation of patients with head and neck squamous cell carcinoma are associated with advanced stage and nodal involvement.头颈部鳞状细胞癌患者外周循环中 CD127(low/-)调节性 T 细胞的频率增加和抑制活性与晚期和淋巴结受累相关。
Immunology. 2013 Nov;140(3):335-43. doi: 10.1111/imm.12144.
3
慢性鼻-鼻窦炎的内型:与疾病表型、发病机制、临床发现和治疗方法的关系。
Allergy. 2022 Mar;77(3):812-826. doi: 10.1111/all.15074. Epub 2021 Sep 15.
4
Guidance factors orchestrating regulatory T cell positioning in tissues during development, homeostasis, and response.指导因素协调调节性 T 细胞在组织中的定位,包括在发育、稳态和反应期间。
Immunol Rev. 2019 May;289(1):129-141. doi: 10.1111/imr.12761.
5
Advances in recurrence and malignant transformation of sinonasal inverted papillomas.鼻腔鼻窦内翻性乳头状瘤复发与恶变的研究进展
Oncol Lett. 2017 Jun;13(6):4585-4592. doi: 10.3892/ol.2017.6089. Epub 2017 Apr 24.
6
The use of rapid and cost-effective blood-based biomarkers in combination with tumour TNM stage for individual head and neck cancer patient treatment selection.使用快速且具有成本效益的血液生物标志物,结合肿瘤TNM分期,用于个体头颈癌患者的治疗选择。
Med Oncol. 2017 Apr;34(4):63. doi: 10.1007/s12032-017-0912-7. Epub 2017 Mar 18.
Intratumor hypoxia promotes immune tolerance by inducing regulatory T cells via TGF-β1 in gastric cancer.肿瘤内缺氧通过 TGF-β1 在胃癌中诱导调节性 T 细胞促进免疫耐受。
PLoS One. 2013 May 27;8(5):e63777. doi: 10.1371/journal.pone.0063777. Print 2013.
4
FOXP3-positive regulatory T lymphocytes and epithelial FOXP3 expression in synchronous normal, ductal carcinoma in situ, and invasive cancer of the breast.FOXP3 阳性调节性 T 淋巴细胞和上皮 FOXP3 表达在同步的正常、导管原位癌和乳腺浸润性癌中。
Breast Cancer Res Treat. 2013 Jun;139(2):381-90. doi: 10.1007/s10549-013-2556-4. Epub 2013 May 28.
5
Paranasal sinus squamous cell carcinoma incidence and survival based on Surveillance, Epidemiology, and End Results data, 1973 to 2009.基于监测、流行病学和最终结果数据的鼻窦鳞状细胞癌发病率和生存率,1973 年至 2009 年。
Cancer. 2013 Jul 15;119(14):2602-10. doi: 10.1002/cncr.28108. Epub 2013 May 14.
6
Intracellular CTLA4 and regulatory T cells in patients with laryngeal squamous cell carcinoma.喉鳞状细胞癌患者的细胞内 CTLA4 和调节性 T 细胞。
Immunol Invest. 2013;42(2):81-90. doi: 10.3109/08820139.2012.708376. Epub 2012 Dec 19.
7
Comprehensive analysis of current approaches to inhibit regulatory T cells in cancer.全面分析抑制癌症中调节性 T 细胞的现有方法。
Oncoimmunology. 2012 May 1;1(3):326-333. doi: 10.4161/onci.18852.
8
A CCR4 antagonist combined with vaccines induces antigen-specific CD8+ T cells and tumor immunity against self antigens.一种 CCR4 拮抗剂与疫苗联合使用可诱导针对自身抗原的抗原特异性 CD8+ T 细胞和肿瘤免疫。
Blood. 2011 Nov 3;118(18):4853-62. doi: 10.1182/blood-2011-01-329656. Epub 2011 Sep 9.
9
Increased frequencies of CD4+ CD25+ FOXP3+ regulatory T cells in human nasal inverted papilloma.人类鼻腔内翻性乳头状瘤中 CD4+ CD25+ FOXP3+ 调节性 T 细胞的频率增加。
Head Neck. 2011 Jul;33(7):1005-12. doi: 10.1002/hed.21581. Epub 2010 Dec 6.
10
Serum IL10 and circulating CD4(+) CD25(high) regulatory T cell numbers as predictors of clinical outcome and survival in patients with head and neck squamous cell carcinoma.血清白细胞介素 10 和循环 CD4(+) CD25(high) 调节性 T 细胞数量作为头颈部鳞状细胞癌患者临床结局和生存的预测指标。
Head Neck. 2011 Mar;33(3):415-23. doi: 10.1002/hed.21464.